MET and RON receptor tyrosine kinases in colorectal adenocarcinoma: molecular options as drug targets and antibody-drug conjugates for remedy

• Johnny Torres

Superior colorectal adenocarcinoma (CRAC), featured by distinctive histopathological look, distant organ metastasis, acquired chemoresistance, and tumorigenic stemness is a bunch of heterogeneous cancers with distinctive genetic signatures and malignant phenotypes. Remedy of CRAC is a daunting exercise for oncologists. In the mean time, quite a few strategies along with molecular specializing in using therapeutic monoclonal…